HK Inno.N Corp Relative Valuation - HK Inno.N Corp - Alpha Spread
H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 50 400 KRW -0.2%
Market Cap: 1.4T KRW
Have any thoughts about
HK Inno.N Corp?
Write Note

Relative Value

The Relative Value of one HK Inno.N Corp stock under the Base Case scenario is 77 498.57 KRW. Compared to the current market price of 50 400 KRW, HK Inno.N Corp is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
77 498.57 KRW
Undervaluation 35%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
63
Median 3Y
1.4
Median 5Y
1.3
Industry
2.6
Forward
1.5
vs History
65
vs Industry
22
Median 3Y
27.9
Median 5Y
27.7
Industry
22.9
Forward
19.7
vs History
57
vs Industry
29
Median 3Y
17.7
Median 5Y
17.5
Industry
17.6
vs History
vs Industry
12
Median 3Y
-28
Median 5Y
-27.8
Industry
25.2
vs History
17
vs Industry
62
Median 3Y
1
Median 5Y
1
Industry
2.2
vs History
25
vs Industry
59
Median 3Y
1.6
Median 5Y
1.6
Industry
2.7
Forward
1.7
vs History
44
vs Industry
56
Median 3Y
3.8
Median 5Y
3.8
Industry
5.4
vs History
75
vs Industry
31
Median 3Y
21.1
Median 5Y
20.9
Industry
13.9
Forward
11.9
vs History
72
vs Industry
25
Median 3Y
22.7
Median 5Y
22.6
Industry
17.3
Forward
15.8
vs History
60
vs Industry
26
Median 3Y
21.4
Median 5Y
21.3
Industry
16.1
vs History
35
vs Industry
15
Median 3Y
31.8
Median 5Y
30.9
Industry
18.8
vs History
17
vs Industry
64
Median 3Y
0.8
Median 5Y
0.8
Industry
2

Multiples Across Competitors

Competitors Multiples
HK Inno.N Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
HK Inno.N Corp
KOSDAQ:195940
1.4T KRW 1.7 26.1 13.6 20.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
843.2B USD 21.7 114.8 57.4 64.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.3 38.2 25.5 29.2
US
Johnson & Johnson
NYSE:JNJ
385.8B USD 4.5 10.1 12.4 16.1
US
Merck & Co Inc
NYSE:MRK
278.3B USD 4.5 20.3 13.7 16.8
CH
Roche Holding AG
SIX:ROG
206.1B CHF 3.5 17.9 10.1 12
UK
AstraZeneca PLC
NASDAQ:AZN
240.2B USD 4.9 37.3 17.1 25.6
CH
Novartis AG
SIX:NOVN
191.2B CHF 4.6 13.8 10.9 16.1
US
Pfizer Inc
NYSE:PFE
162B USD 2.9 -62.4 12.6 20.4
P/E Multiple
Earnings Growth
KR
H
HK Inno.N Corp
KOSDAQ:195940
Average P/E: 34.8
26.1
114%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
114.8
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
38.2
90%
US
Johnson & Johnson
NYSE:JNJ
10.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
CH
Roche Holding AG
SIX:ROG
17.9
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.3
175%
CH
Novartis AG
SIX:NOVN
13.8
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -62.4
712%

See Also

Discover More
Back to Top